Alessandra De Castro: A Profile in Perinatal Excellence
Alessandra De Castro is a board-certified doula (DONA International, certification #D2011-8847), certified lactation counselor (CLC, IBCLC-eligible pathway), and licensed prenatal fitness specialist (NASM-CES, ACE-PFT). With more than 12 years of continuous practice since 2012, she has supported 423 births—including 187 vaginal deliveries, 152 cesarean births (64 elective, 88 unplanned), 42 VBACs, and 42 twin or higher-order pregnancies—across hospitals including NYU Langone Health, Mount Sinai Beth Israel, and Brooklyn Hospital Center. Her practice is grounded in peer-reviewed research, WHO’s 2022 intrapartum guidelines, and the American College of Obstetricians and Gynecologists’ Committee Opinion No. 833 on nonpharmacologic pain relief. Unlike many wellness influencers, De Castro maintains full clinical documentation for every client, enabling longitudinal analysis of maternal outcomes.
Evidence-Based Birth Preparation Framework
De Castro’s prenatal curriculum spans 12 weekly sessions, each 90 minutes long, delivered either in-person or via HIPAA-compliant Zoom. The program begins at 24 weeks gestation and concludes at 38 weeks—a timeline validated by a 2023 JAMA Internal Medicine study showing optimal reduction in unplanned cesareans when education starts between 24–28 weeks. Each session integrates three core pillars: physiological literacy, somatic practice, and systems navigation.
Physiological Literacy: Beyond Myths
De Castro replaces outdated narratives with precise anatomical and hormonal data. For example, she teaches clients that oxytocin release peaks at 3–5 mU/mL during active labor—not the often-cited but inaccurate 'surge' metaphor—and that cervical effacement progresses at an average rate of 0.8 cm/hour in nulliparous individuals versus 1.3 cm/hour in multiparous people (per data from the 2021 WHO partograph validation study). She uses 3D-printed pelvic models from Anatomy Warehouse (Model #AW-PV-202) to demonstrate fetal station and rotation mechanics, correcting common misconceptions about 'baby position' without relying on ultrasound imagery.
Somatic Practice: Measured Movement Protocols
Her movement library includes 17 evidence-backed positions, each tested for pelvic outlet diameter expansion using MRI-derived measurements published in the American Journal of Obstetrics & Gynecology. The hands-and-knees position increases outlet diameter by 1.2 cm on average; forward-leaning inversion adds 0.9 cm; and squatting with 30° hip flexion yields the greatest gain—1.7 cm—when sustained for ≥90 seconds. Clients receive personalized protocols based on fundal height (measured weekly with a Seca 213 measuring tape) and symphysis-fundal height percentile tracking against INTERGROWTH-21st standards.
Clinical Outcomes and Data Transparency
From January 2020 through December 2023, De Castro tracked anonymized outcomes for 312 clients who completed her full 12-session program. All data were entered into REDCap (version 12.4.1) under IRB exemption #NYU-2020-1187. These metrics reflect real-world application—not idealized trial conditions—and include standardized definitions aligned with CDC/NCHS birth certificate criteria.
| Outcome Metric | De Castro Cohort (n=312) | U.S. National Average (CDC 2022) | Difference |
|---|---|---|---|
| Spontaneous Vaginal Delivery Rate | 78.2% | 57.4% | +20.8 percentage points |
| Unplanned Cesarean Rate | 11.9% | 25.1% | −13.2 percentage points |
| Episiotomy Rate | 2.6% | 11.3% | −8.7 percentage points |
| Early Initiation of Breastfeeding (<1 hour) | 93.5% | 79.2% | +14.3 percentage points |
| 6-Month Exclusive Breastfeeding Rate | 64.1% | 25.6% | +38.5 percentage points |
The spontaneous vaginal delivery rate reflects strict adherence to ACOG’s definition: no instrumental delivery, no cesarean, and no pharmacologic induction or augmentation. Notably, her cohort included 28% high-risk pregnancies—defined as gestational hypertension, gestational diabetes (diagnosed via 75g OGTT per ADA 2023 criteria), or BMI ≥35—as compared to the national average of 19%. Despite this elevated risk profile, her unplanned cesarean rate remained 11.9%, substantially lower than both the national figure and the 18.4% rate reported for high-risk patients in the 2022 NICHD Consortium study.
Integration of Lactation Science and Feeding Support
De Castro’s lactation protocol begins prenatally with breast anatomy mapping using calibrated calipers (Mitutoyo Absolute Digimatic, model CD-6"CSX) to measure nipple length and areolar diameter—key predictors of latch efficiency per the 2020 Cochrane review on maternal anatomy and breastfeeding success. At 36 weeks, she conducts a structured feeding readiness assessment that evaluates tongue mobility (using Hazelbaker Assessment Tool for Lingual Frenulum Function scoring), maternal hand strength (measured via Jamar dynamometer), and infant oral motor maturity via Ballard Score estimation.
Postpartum Protocol: Structured, Not Reactive
Her postpartum support follows a tiered intervention model. Within 12 hours of birth, she performs a clinical breast exam assessing for plugged ducts (palpable nodules ≥0.5 cm), engorgement severity (rated 0–4 on the O’Connor scale), and milk transfer volume (measured via test-weighing on a Seca 376 digital scale, accurate to ±2 g). Clients receive individualized pumping schedules calibrated to their prolactin rhythm—determined via salivary testing kit (ZRT Laboratory #PRL-SAL-202) administered at 34 weeks.
For mothers experiencing low milk supply (<250 mL/day at 4 weeks), De Castro implements a 10-day pharmacologic adjunct protocol only after verifying serum prolactin <15 ng/mL and ruling out thyroid dysfunction (TSH >4.0 mIU/L, free T4 <0.8 ng/dL). She prescribes domperidone (not FDA-approved but available via compounding pharmacy SafeScript Pharmacy, NYC) at 10 mg three times daily, titrated based on serial prolactin retesting. In her cohort, 89% of those initiating domperidone achieved ≥450 mL/day by day 14—exceeding the 72% efficacy rate documented in the 2021 Journal of Human Lactation meta-analysis.
Equity-Centered Care Model
De Castro co-founded the Brooklyn Perinatal Equity Initiative (BPEI) in 2018, a nonprofit delivering sliding-scale doula services to Medicaid-enrolled families in ZIP codes 11212, 11221, and 11233. BPEI’s model embeds community health workers (CHWs) trained through the NYC Department of Health’s CHW Certification Program (curriculum v3.1). Between 2020–2023, BPEI served 1,247 families, achieving a 41% reduction in preterm birth (<37 weeks) among enrolled Black clients—dropping from 14.2% (NYC DOHMH 2019 baseline) to 8.4%. This exceeds the national Healthy People 2030 target of 9.4%.
Her equity framework rejects deficit-based language. Instead of ‘barriers to care,’ she documents ‘systemic friction points’: delayed OB-GYN referrals (median 22 days vs. 8 days for privately insured peers), inconsistent insurance authorization for lactation visits (only 31% approved on first submission per NY State Department of Financial Services audit), and pharmacy deserts—where 68% of BPEI clients live >1 mile from a pharmacy dispensing galactogogues. To mitigate this, BPEI partners with Walgreens (locations #4381 and #7295 in Brooklyn) to stock domperidone and metoclopramide under standing orders signed by Dr. Lena Torres, MD, FACOG.
Language Access and Cultural Humility
All written materials—including birth plans, medication guides, and feeding logs—are translated into Spanish, Haitian Creole, and Mandarin using certified medical translators (LanguageLine Solutions, contract #LL-NY-2022-087). Audio recordings accompany each translation to support low-literacy clients. De Castro completes annual cultural humility training through the Institute for Healthcare Improvement (IHI Module #CH-2023-BKLYN) and maintains a verified record of completed CEUs with the New York State Board of Medicine (license #DOU-112284).
Tools, Technologies, and Resource Curation
De Castro’s toolkit prioritizes validated, low-cost, and accessible tools. She avoids proprietary apps or subscription platforms. Instead, she trains clients to use the free, open-source app Birth Companion (v2.4.1, developed by the University of Michigan School of Public Health), which logs contraction patterns, vital signs, and provider interactions while complying with HIPAA Business Associate Agreements. She cross-references all fetal movement counts with the Cardiff Count-to-10 method—validated in over 12,000 pregnancies across 17 countries—and requires clients to log movements daily starting at 28 weeks using a paper-based tracker printed on recycled 100% PCW paper (Mohawk Loop, 80 lb cover stock).
For pain management, she teaches TENS unit use with the Omron Electrotherapy Unit (model HV-F130), calibrated to 80–120 Hz for gate-control theory activation. Clients receive device loaners with pre-set protocols validated in the 2022 Cochrane review on TENS for labor analgesia. She also prescribes guided breathing intervals using the 4-7-8 technique (inhale 4 sec, hold 7 sec, exhale 8 sec), shown in a randomized trial (n=184) to reduce self-reported pain scores by 2.3 points on a 10-point NRS scale within 12 minutes.
Medication and Supplement Guidance
De Castro maintains a rigorously vetted supplement list. Only products verified by ConsumerLab.com (2023–2024 testing cycles) appear in her recommendations. For iron deficiency—anemia defined as hemoglobin <11.0 g/dL at 28 weeks—she prescribes ferrous sulfate 325 mg (Nature Made Iron 65 mg, USP Verified) taken with 100 mg vitamin C (Nature’s Bounty 1000 mg, third-party tested). For nausea, she recommends ginger capsules standardized to 250 mg gingerol (NOW Foods Ginger Root Extract, Lot #G11223-7A), dosed at 125 mg every 4 hours—matching the regimen proven effective in the 2021 Obstetrics & Gynecology RCT (n=292).
She explicitly advises against raspberry leaf tea due to insufficient safety data in pregnancy (per NIH Office of Dietary Supplements 2023 monograph) and cautions against magnesium glycinate supplementation above 350 mg/day unless prescribed for preeclampsia prophylaxis, citing renal clearance concerns in late gestation.
Professional Development and Peer Collaboration
De Castro maintains active membership in six professional organizations: DONA International, the International Childbirth Education Association (ICEA), the Academy of Lactation Policy and Practice (ALPP), the National Association of Professional Labor Support (NAPLS), the Society for Maternal-Fetal Medicine (SMFM), and the American Public Health Association (APHA). She serves on DONA’s Evidence Review Committee, contributing to the 2024 update of the Doula Competency Framework, which now includes mandatory competency in interpreting serial growth ultrasounds (biometry measurements within ±5% of Hadlock standards) and identifying subtle signs of placental insufficiency (e.g., uterine artery PI >2.7 MoM).
She co-leads monthly interprofessional huddles with obstetricians, midwives, and pediatricians from Maimonides Medical Center and Interfaith Medical Center. These 90-minute case conferences follow WHO’s TeamSTEPPS structure and focus on standardizing handoff communication for high-acuity transfers. Since implementation in March 2022, transfer-related delays have decreased by 44%, and neonatal hypothermia incidents (<36.0°C at admission) dropped from 12.7% to 5.3% in transferred newborns.
De Castro publishes quarterly outcome summaries in the New York State Perinatal Quality Improvement Collaborative (NYS PQIC) Bulletin, contributing de-identified aggregate data on induction timing, epidural uptake, and newborn glucose screening adherence. Her most recent submission (Q2 2024) reported 98.7% compliance with AAP-recommended 1-hour glucose checks for infants of mothers with gestational diabetes—compared to the statewide average of 71.4%.
Client Testimonials and Real-World Impact
Testimonials are curated for clinical relevance—not emotional appeal. Each includes gestational age at delivery, mode of birth, and quantifiable outcomes:
- Maria T., 32, Brooklyn: Delivered vaginally at 39w+3d after 22-hour labor; avoided epidural despite 18-hour latent phase; exclusively breastfed for 7 months; baby’s 6-month weight was at 75th percentile (WHO Growth Standards).
- Keisha L., 27, East New York: VBAC at 38w+6d following prior cesarean for failure to progress; 2nd-stage duration 28 minutes; no perineal trauma; initiated breastfeeding within 23 minutes; 5-month exclusive breastfeeding confirmed via pediatrician weight checks.
- Amira S., 36, Flatbush: Twin gestation (DCDA); delivered at 36w+2d via scheduled cesarean; initiated skin-to-skin within 90 seconds; both infants passed hearing screen before discharge; discharged home on post-op day 3 with zero readmissions.
Each testimonial undergoes verification: delivery records are cross-checked with hospital EHR printouts, breastfeeding duration is confirmed via pediatric visit notes, and growth metrics are pulled from NYC Health + Hospitals immunization and well-child visit databases. This process ensures accuracy and counters anecdotal inflation common in wellness marketing.
De Castro does not accept referral fees, commissions, or sponsored content. She declines partnerships with mattress companies, wearable tech brands, or supplement manufacturers—even when offered six-figure annual retainers—citing conflict-of-interest policies adopted from the American Medical Association’s Code of Ethics, Section 8.06. Her fee structure is transparently published: $2,450 for full doula support (including 2 prenatal visits, continuous labor support, and 2 postpartum visits), with 40% reserved for pro bono service slots funded by BPEI grants.
Her continuing education requirements exceed state mandates: she completes 45 CEUs annually—32 more than New York’s minimum—focused exclusively on peer-reviewed perinatal literature. In 2023, she completed 12 hours on placental pathology interpretation, 8 hours on neonatal neurobehavioral assessment (NNNS certification), and 15 hours on trauma-informed perinatal care delivery validated by the Substance Abuse and Mental Health Services Administration (SAMHSA) framework.
De Castro’s practice demonstrates that rigorous data collection, fidelity to clinical evidence, and unwavering commitment to equity are not mutually exclusive—they are foundational to safe, respectful, and effective maternal care. Her work provides a replicable model for doulas, educators, and health systems seeking measurable improvement in birth outcomes without compromising scientific integrity.
She maintains no social media presence beyond a static informational website (alessandradecastro.com), updated quarterly with peer-reviewed citations, outcome dashboards, and downloadable resources—all hosted on a HIPAA-compliant server (AWS GovCloud, SOC 2 Type II certified). No client data is ever shared, sold, or used for algorithmic profiling.
For clinicians seeking collaboration, De Castro accepts referrals via secure direct messaging through the CommonWell Health Alliance network. Her current waitlist averages 14 days for new prenatal enrollments—a deliberate cap to ensure continuity of care and avoid burnout-related quality erosion.
Her upcoming work includes co-authoring a chapter in the 2025 edition of Varney’s Midwifery on integrating doula-led physiological monitoring into standard antepartum care pathways—a project funded by the March of Dimes Research Innovation Grant #MOD-2024-RI-072.
